AstraZeneca

Recent news

• SC 13G: Statement of acquisition of beneficial ownership by individuals-AstraZeneca PLC(9.9%),Alexion Pharmaceuticals, Inc.(9.9%)
  SEC · 10/28
• J.P. Morgan Maintains AstraZeneca(AZN.US) With Buy Rating, Cuts Target Price to $215.74
  Market Newswire · 9/1
• Japan System Techniques: Initiation of COPD patient education joint program with Astrazeneca Co., Ltd. in Koryo-cho, Nara Prefecture - DELAYED
  JPX · 7/29
• TD Cowen Maintains AstraZeneca(AZN.US) With Buy Rating, Announces Target Price $240
  Market Newswire · 9/1
• CSPC PHARMA: RECEIPT OF US$1.2 BILLION UPFRONT PAYMENT UNDER THE STRATEGIC COLLABORATION AND LICENSE AGREEMENT WITH ASTRAZENECA FOR THE DEVELOPMENT OF INNOVATIVE LONG-ACTING PEPTIDE MEDICINES
  HKEX · 5/29
• J.P. Morgan Reaffirms Their Buy Rating on AstraZeneca (AZN)
  TipRanks · 9/1
• Berenberg Bank Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $215.74
  Market Newswire · 9/3
• LBT Innovations Ltd: ASTRAZENECA SALE & SERVICE CONTRACT UP TO A$4.1M
  8/7
• Monopar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-AstraZeneca PLC(9.9%),Alexion Pharmaceuticals, Inc.(9.9%)
  SEC · 10/28
• Deutsche Bank Maintains AstraZeneca(AZN.US) With Sell Rating, Cuts Target Price to $155.06
  Market Newswire · 9/2

Headlines are aggregated automatically and are not independently verified or edited by our team.